Abstract:Background Turner's syndrome (TS) is the most common genetic abnormality affecting females and is characterised by complete or partial absence of the X chromosome. Mortality is predominantly related to cardiovascular disease (1). Risk of life-threatening aortic dissection is 40 per 100,000 (2). Indexed aorta size (ASI) to body surface area (BSA) >20mm/m2 is considered abnormal. An ASI of ≥25mm/m2 is associated with increased risk of aortic dissection (3). Despite this there is a paucity of data in the literature regarding TS cardiovascular disease and providing evidence-based care can be challenging. Purpose Define cardiovascular disease, with focus upon aortopathy in our TS Cardiovascular Clinic (TCC). Methods Single centre retrospective medical record analysis of 248 women with TS (2021-2024) Results Patient baseline characteristics; mean age 37 years (range 18-75yrs), height 150cm (132-169cm), weight 62kg (37-130kg), BSA 1.55m2 (1.19-2.17m2). 65 patients (29%) had bicuspid aortic valve (BAV), 19 (8%) and 5 (3%) had repaired and un-repaired aortic coarctation (CoA) respectively. 30 (13%) had other congenital heart disease, with most common was partial anomalous pulmonary venous connection (12 patients: 5%). 22/248 patients had previous aortic root surgery; 20 elective (mean ASI 29mm/m2, range 26-33mm/m2, mean age at time of surgery 42 years); 2 presented with aortic dissection (ASI 21mm/m2; pregnant, BAV & 24mm/m2; tri-leaflet aortic valve, TAV). Data was available for 221 unoperated patients (figure 1). The site of maximal dimension was observed at the sinus of Valsalva in 70% compared to 30% at the ascending aorta. 130 patients (59%) had maximal ASI of 25mm/m2. 4 patients (2%) had an absolute maximal dimension of 40mm with ASI of 23mm/m2 for all four. 9/11 patients with dimension ≥25mm/m2 or 40mm had a body mass index (BMI) >25kg/m2. Review of medical history for patients at and above threshold for risk of aortic dissection revealed referral to or previous discussion in an Aortic multi-disciplinary meeting (MDT) with a plan for ongoing surveillance. 57 patients (35%) with TAV had significant aortopathy (mean age 46years, range 19-75years) compared with 33 (51%) with BAV (mean age 39yrs, range 22-72 years) (figure 2). Review of patients >55years of age demonstrated a very similar burden of aortopathy in both TAV (14%) and BAV (15%) populations. Conclusions A high burden of cardiovascular disease exists within our TS population. There is a very high prevalence of aortopathy, increasingly with age and both with and without the presence of a bicuspid aortic valve. More published data is needed to help better define those at risk.

Ear and hearing problems in 44 middle-aged women with Turner's syndrome

Height Standard Deviation Score is Related to Karyotypes and Birth Weight in Girls with Turner Syndrome

Psychiatric disorders and comorbidity in women with Turner Syndrome: a retrospective national cohort study

Neurodevelopmental and psychiatric disorders in females with Turner syndrome: a population-based study

The impact of amplification on quality of life in women with Turner syndrome

A Diagnosis of Turner Syndrome in the Eighth Decade of Life

Emotional-psychological concerns of Turner’s patients regarding social discrimination

Prevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X/47,XXX): Results from the InsighTS Registry

Middle ear cholesteatoma prevalence in over 3,600 children with Turner Syndrome

Reproductive health in Turner's syndrome: from puberty to pregnancy

Pregnancies in women with Turner syndrome: a retrospective multicentre UK study

Increased detection of co-morbidities with evaluation at a dedicated adult Turner syndrome clinic

Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group

Visual Impairment in Women with Turner Syndrome—A 49-Year Literature Review

Liver biochemical abnormalities in Turner syndrome: A comprehensive characterization of an adult population

Comprehensive Oral Diagnosis and Management for Women with Turner Syndrome

Experiences of social interaction in young women with Turner syndrome: A qualitative study

Evaluation of cardiovascular disease in the turner syndrome population in Northern Ireland

Recognition and management of adults with Turner syndrome: From the transition of adolescence through the senior years

Normalization of puberty and adult height in girls with Turner syndrome: results of the Swedish Growth Hormone trials initiating transition into adulthood

Cardiovascular health in women with turner's syndrome: a 3-year single centre audit